Abstract
Tenapanor (RDX-5791, AZD-1722) is a first-in-class oral inhibitor of the sodium/proton exchanger NHE3 (Na+/H+ exchanger 3) under development at Ardely......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
